Barclays’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2 | Sell |
|
|||||
|
2025
Q2 | $0 | Sell |
|
|||||
|
2025
Q1 | $59K | Sell |
|
|||||
|
2024
Q4 | $71K | Buy |
|
|||||
|
2024
Q3 | $197K | Buy |
|
|||||
|
2024
Q2 | $72K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $29K | Sell |
|
|||||
|
2023
Q1 | $705K | Sell |
|
|||||
|
2022
Q4 | $2.11M | Buy |
|
|||||
|
2022
Q3 | $2M | Buy |
|
|||||
|
2022
Q2 | $19K | Sell |
|
|||||
|
2022
Q1 | $126K | Sell |
|
|||||
|
2021
Q4 | $1.25M | Buy |
|
|||||
|
2021
Q3 | $611K | Buy |
|
|||||
|
2021
Q2 | $380K | Sell |
|
|||||
|
2021
Q1 | $1.45M | Sell |
|
|||||
|
2020
Q4 | $1.8M | Sell |
|
|||||
|
2020
Q3 | $2.89M | Sell |
|
|||||
|
2020
Q2 | $7.02M | Buy |
|
|||||
|
2020
Q1 | $1.44M | Buy |
|
|||||
|
2019
Q4 | $306K | Buy |
|
|||||
|
2019
Q3 | $119K | Sell |
|
|||||
|
2019
Q2 | $192K | Buy |
|
|||||
|
2019
Q1 | $92K | Sell |
|
|||||
|
2018
Q4 | $286K | Sell |
|
|||||
|
2018
Q3 | $429K | Buy |
|
|||||
|
2018
Q2 | $42K | Sell |
|
|||||
|
2018
Q1 | $125K | Sell |
|
|||||
|
2017
Q4 | $326K | Buy |
|
|||||
|
2017
Q3 | $134K | Buy |
|
|||||
|
2017
Q2 | $163K | Buy |
|
|||||
|
2017
Q1 | $18K | Sell |
|
|||||
|
2016
Q4 | $42K | Sell |
|
|||||
|
2016
Q3 | $160K | Buy |
|
|||||
|
2016
Q2 | $2K | Sell |
|
|||||
|
2016
Q1 | $41K | Buy |
|
|||||
|
2015
Q4 | $5K | Sell |
|
|||||
|
2015
Q3 | $298K | Buy |
|
|||||
|
2015
Q2 | $12K | Sell |
|
|||||
|
2015
Q1 | $31K | Sell |
|
|||||
|
2014
Q4 | $50K | Sell |
|
|||||
|
2014
Q3 | $65K | Buy |
|
|||||
|
2014
Q2 | $14K | Sell |
|
|||||
|
2014
Q1 | $33K | Sell |
|
|||||
|
2013
Q4 | $51K | Buy |
|